NCT00167999已完成不适用
Effects of Piperacillin-Tazobactam Use on the Prevalence Rate of Extended-Spectrum Beta-Lactamase (ESBL) Producing Escherichia Coli and Klebsiella Pneumoniae in Hematology and Oncology Units.
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 200 人开始时间: 2005年2月最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
To determine the value of increasing use of piperacillin/tazobactam as empiric therapy and restricting extended-spectrum cephalosporins in reducing the cases of ESBL producing Escherichia coli and Klebsiella pneumoniae in hematology and oncology units
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 15 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Eligible patients of either sex, 15 years of age or older
- •Patients who are admitted to the department of hematology and oncology
- •Provide written informed consent
排除标准
- •Patients who have hypersensitivity to β-lactam antibiotics
- •Female who are pregnant or breast-feeding
- •Any underlying conditions or non-infectious diseases that will be ultimately fatal within 30 days
研究者
相似试验
已完成
3 期
Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas AeruginosaPseudomonas Aeruginosa InfectionNCT01577368Fundación Pública Andaluza para la gestión de la Investigación en Sevilla76
已完成
不适用
Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections.Urinary InfectionsNCT00195286Wyeth is now a wholly owned subsidiary of Pfizer180
已完成
4 期
Tazocin Intervention StudyBacterial InfectionsNCT00478855Wyeth is now a wholly owned subsidiary of Pfizer500
Unknown
2 期
Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial PneumoniaNosocomial PneumoniaNCT01796717Tianjin Medical University Cancer Institute and Hospital50
招募中
不适用
PK of Piperacillin/Tazobactam in Adults Undergoing ECMOAcute Respiratory Failure With HypoxiaNCT03467854Columbia University10